
Laurus Labs Hits New 52-Week High of Rs.1040, Marking Significant Milestone
2025-12-01 11:27:13Laurus Labs, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.1040 today, underscoring a notable phase of momentum in its stock performance. This milestone reflects the company’s sustained upward trajectory amid a broadly positive market environment.
Read More
Laurus Labs Hits New 52-Week High of Rs.1040 Marking Significant Milestone
2025-12-01 11:27:12Laurus Labs, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high today, touching Rs.1040. This milestone reflects the stock’s sustained momentum and strong performance over the past year, significantly outpacing broader market indices.
Read More
Laurus Labs Hits New 52-Week High of Rs.1040 Marking Strong Market Momentum
2025-12-01 11:27:09Laurus Labs, a prominent player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.1040 today, underscoring a significant milestone in its market performance. This achievement reflects sustained momentum supported by robust financial metrics and favourable market conditions.
Read More
Laurus Labs Hits New 52-Week High of Rs.1040 Marking Significant Milestone
2025-12-01 11:27:09Laurus Labs has reached a new 52-week high, touching Rs.1040 today, underscoring a notable milestone in its market performance within the Pharmaceuticals & Biotechnology sector. This achievement reflects sustained momentum supported by strong financial metrics and positive quarterly results.
Read More
Laurus Labs Stock Hits All-Time High at Rs.1036 Amid Strong Performance
2025-12-01 09:33:06Laurus Labs has reached a significant milestone by hitting a new 52-week high of Rs.1036, marking an all-time peak for the pharmaceutical and biotechnology company. This achievement reflects a sustained period of robust performance across multiple financial metrics and market indicators.
Read More
Laurus Labs Sees Notable Surge in Open Interest Amid Rising Market Momentum
2025-11-27 15:00:17Laurus Labs, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a significant rise in open interest in its derivatives segment, signalling heightened market activity and evolving investor positioning. This development coincides with the stock trading near its 52-week high and outpacing sector performance, reflecting a dynamic phase for the company’s shares.
Read More
Laurus Labs Sees Notable Surge in Open Interest Amid Rising Market Momentum
2025-11-27 14:00:18Laurus Labs, a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and evolving investor positioning. This development coincides with the stock trading near its 52-week high and outpacing sector performance, reflecting growing investor focus on the company’s prospects.
Read More
Laurus Labs Sees Notable Surge in Derivatives Open Interest Amid Rising Market Momentum
2025-11-27 13:00:12Laurus Labs has experienced a significant rise in open interest within its derivatives segment, reflecting heightened market activity and shifting investor positioning. This surge accompanies a positive price trend and increased trading volumes, signalling evolving market sentiment around the pharmaceutical and biotechnology firm.
Read More
Laurus Labs Sees Notable Surge in Open Interest Amid Rising Market Momentum
2025-11-27 12:00:12Laurus Labs Ltd has experienced a significant rise in open interest in its derivatives segment, signalling heightened market activity and evolving investor positioning. This surge accompanies a positive price trend and increased trading volumes, reflecting growing interest in the pharmaceutical and biotechnology sector.
Read MoreAnnouncement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
02-Dec-2025 | Source : BSEPlease see annexed enclosure
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
19-Nov-2025 | Source : BSEPlease see annexed enclosure
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
12-Nov-2025 | Source : BSEPlease see annexed enclosure.
Corporate Actions
No Upcoming Board Meetings
Laurus Labs Ltd has declared 40% dividend, ex-date: 31 Oct 25
Laurus Labs Ltd has announced 2:10 stock split, ex-date: 29 Sep 20
No Bonus history available
No Rights history available






